AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day-To The Moon - Tiger Brokers Online Investing Community - To The Moon

Like
Comment
Favorite

AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day

Dow Jones07-27

DJ AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day

This article was automatically generated by MarketWatch using technology from Automated Insights.

The AstraZeneca PLC ADR $(AZN)$ shed 0.50% to $78.13 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 1.03% to 17,357.88 and the Dow Jones Industrial Average rising 1.64% to 40,589.34.

This was the ADR's second consecutive day of losses.

AstraZeneca PLC ADR closed $2.73 short of its 52-week high ($80.86), which the company reached on June 6th.

The ADR demonstrated a mixed performance when compared to some of its competitors Friday, as Eli Lilly & Co. $(LLY)$ fell 2.02% to $804.62, Biogen Inc. $(BIIB)$ fell 7.15% to $211.17, and Johnson & Johnson $(JNJ)$ rose 0.63% to $160.64.

Trading volume (5.9 M) eclipsed its 50-day average volume of 3.7 M.

Data source: Dow Jones Market Data, FactSet. Data compiled July 26, 2024.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

July 26, 2024 17:24 ET (21:24 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Like

Report

Comment

empty

No comments yet

Most Discussed

7x24

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2454730595?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-07-27 05:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2454730595","market":"sh","top_or_hot":-1,"title":"AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<p>\nDJ AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day\n</p>\n<p>\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n</p>\n<p>\n     The AstraZeneca PLC ADR <a href=\"https://laohu8.com/S/AZN\">$(AZN)$</a> shed 0.50% to $78.13 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.03% to 17,357.88 and the Dow Jones Industrial Average  rising 1.64% to 40,589.34. \n</p>\n<p>\n     This was the ADR's second consecutive day of losses. \n</p>\n<p>\n     AstraZeneca PLC ADR closed $2.73 short of its 52-week high ($80.86), which the company reached on June 6th. \n</p>\n<p>\n     The ADR demonstrated a mixed performance when compared to some of its competitors Friday, as Eli Lilly &amp; Co. <a href=\"https://laohu8.com/S/LLY\">$(LLY)$</a> fell 2.02% to $804.62, Biogen Inc. <a href=\"https://laohu8.com/S/BIIB\">$(BIIB)$</a> fell 7.15% to $211.17, and Johnson &amp; Johnson <a href=\"https://laohu8.com/S/JNJ\">$(JNJ)$</a> rose 0.63% to $160.64. \n</p>\n<p>\n     Trading volume (5.9 M) eclipsed its 50-day average volume of 3.7 M. \n</p>\n<p>\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 26, 2024. \n</p>\n<p>\n     This content was created by MarketWatch, which is operated by Dow Jones &amp; Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 26, 2024 17:24 ET (21:24 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-07-27 05:24 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://dowjonesnews.com/newdjn/logon.aspx?AL=N><strong>Dow Jones</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>DJ AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     The AstraZeneca ...</p>\n\n<a href=\"https://dowjonesnews.com/newdjn/logon.aspx?AL=N\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"AZN","symbol_name":"阿斯利康","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2454730595","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2454730595","pubTimestamp":1722029040,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.The AstraZeneca PLC ADR  shed 0.50% to $78.13 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.03% to 17,357.88 and the Dow Jones Industrial Average  rising 1.64% to 40,589.34.This was the ADR's second consecutive day of losses.AstraZeneca PLC ADR closed $2.73 short of its 52-week high , which the company reached on June 6th.The ADR demonstrated a mixed performance when compared to some of its competitors Friday, as Eli Lilly & Co.  fell 2.02% to $804.62, Biogen Inc.  fell 7.15% to $211.17, and Johnson & Johnson  rose 0.63% to $160.64.Trading volume  eclipsed its 50-day average volume of 3.7 M.Data source: Dow Jones Market Data, FactSet. Data compiled July 26, 2024.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and","collect":0,"end_time":0,"defaultTopTitle":"","property":["rate"],"viewcount":null,"language":"en","relate_stocks":{"AZN":"阿斯利康"},"translate_title":"尽管当天亏损，阿斯利康公司ADR的表现仍优于竞争对手","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"AZN":1},"content_text":"DJ AstraZeneca PLC ADR Outperforms Competitors Despite Losses On The Day\n\n\n  This article was automatically generated by MarketWatch using technology from Automated Insights. \n\n\n     The AstraZeneca PLC ADR $(AZN)$ shed 0.50% to $78.13 Friday, on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index  rising 1.03% to 17,357.88 and the Dow Jones Industrial Average  rising 1.64% to 40,589.34. \n\n\n     This was the ADR's second consecutive day of losses. \n\n\n     AstraZeneca PLC ADR closed $2.73 short of its 52-week high ($80.86), which the company reached on June 6th. \n\n\n     The ADR demonstrated a mixed performance when compared to some of its competitors Friday, as Eli Lilly & Co. $(LLY)$ fell 2.02% to $804.62, Biogen Inc. $(BIIB)$ fell 7.15% to $211.17, and Johnson & Johnson $(JNJ)$ rose 0.63% to $160.64. \n\n\n     Trading volume (5.9 M) eclipsed its 50-day average volume of 3.7 M. \n\n\n     Data source: Dow Jones Market Data, FactSet. Data compiled July 26, 2024. \n\n\n     This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal. \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 26, 2024 17:24 ET (21:24 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"hasMoreComments":false,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}